Newsletter Current page: 6

Pneumology deals with diseases of the respiratory tract and is a speciality of internal medicine. The word is derived from the Greek: pneumo = lung, logia = study. In medicine, the subject of pulmonary medicine has received special attention in the last two years through COVID-19. The history of pneumology begins much earlier, of course. […]

SHS is pleased to offer students a practical experience through an internship and to give you an insight into the areas of private equity, funds and growth companies. Simeon Liesenfeld has been an intern at SHS since the beginning of April 2022. Simeon is currently completing his bachelor’s degree in industrial engineering at the Karlsruhe […]

Kerstin Stuck is a new analyst in the SHS team. She is a biologist and business economist by training and thus doubly qualified to assess investment enquiries. In her spare time, she tends to her vegetable garden and chickens when she is not touring Europe in her caravan with her husband and children.

As a healthcare investor, SHS supports its portfolio companies not only with capital, but also with decades of experience and expertise in the healthcare sector. We wanted to know from Dr André Zimmermann, SHS partner and doctor of microbiology, what SHS specifically does for its portfolio companies. Editor: In which areas, apart from capital, does […]

The approval of the worldwide unique, double-walled high pressure balloon catheter “OPN-NC Super High Pressure PTCA Balloon” is a big step for SIS and very good news for all patients in the USA who are affected by serious lesions in the area of the heart vessels. More than 100,000 patients in Europe have already been […]

Advanced Osteotomy Tools AG (AOT), a highly innovative healthcare company in the field of laser-based contactless surgical robots, has a new, highly experienced CEO in Elmar Zurbriggen. Zubriggen took office on 1 April and has previously held responsibilities at various medtech world market leaders. Peter Oprandi, the new CFO, also brings a lot of experience […]

This year we once again hosted the annual Investors’ Day and the shareholders’ meetings of the SHS Funds. To our great pleasure, it was again possible this year to hold the event in the presence of the investors. Investors, portfolio representatives, our senior advisors and healthcare experts were invited to the Hotel Krone in the […]

Today, anyone who has to endure painful dental treatment asks their dentist for an injection as a matter of course. But in the case of a first operation with general anaesthesia, many patients probably ask themselves whether they will really not notice anything of the operation and the pain – despite comprehensive information from the […]

SHS is pleased to be able to offer students the opportunity for practical experience within the framework of an internship in 2022 and to provide them with an insight into the private equity sector. We have been pleased to welcome Charlotte Eusterbrock to SHS since mid-November 2021. Charlotte is currently completing her Bachelor’s degree in […]

As part of a strategic partnership, the German healthcare company AMW will in future focus on the development, approval and licensing of biodegradable transdermal delivery systems. The new French partner AdhexPharma is responsible for series production and lifecycle management and brings with it the best prerequisites for this. “We are pleased that our portfolio company […]

Mitral valve regurgitation (leakage) is one of the very common heart diseases. It is estimated that around 25 million patients worldwide suffer from it. CoreMedic GmbH has developed the ChordArt™ mitral valve repair system, a device for the safe repair of the mitral valve. In a broad, two-year patient study, the ChordArt™ system has now […]

In the development of an urgently needed in-vitro diagnostic test for multiple sclerosis, numares AG relies exclusively on the scientific preliminary work of the University of Oxford. numares works with AI and develops multimarker algorithms for diagnostic tests. With the help of the new MS tests, the transitions between different stages of the disease in […]